Quality Dossier

  • Home
  • Quality Dossier

Comprehensive Quality Documentation

Taj Pharma provides complete quality dossiers for Fenbendazole tablets, including Certificate of Analysis (COA), Method of Analysis (MOA), Batch Manufacturing Records (BMR), process validation, cleaning validation, and comprehensive OOS/OOT summary reports. All documentation follows ICH guidelines and international pharmacopeial standards.

  • Validated analytical methods with complete validation reports
  • Batch-to-batch consistency with detailed BMR documentation
  • Process and cleaning validation with statistical analysis
  • OOS/OOT investigation reports with CAPA documentation

Quality Documentation Package

  • COA: Certificate of Analysis per batch
  • MOA: Method of Analysis with validation
  • BMR: Batch Manufacturing Records
  • Process Validation: Complete validation reports
  • Cleaning Validation: Cleaning protocol validation
📥 Sample Quality Dossier ✉️ Request Full Package

Quality Documentation Components

Complete quality documentation package covering all aspects of Fenbendazole tablet manufacturing and testing.

Certificate of Analysis (COA)

  • Assay: 95-105% of labeled claim
  • Dissolution: Q=80% in 45 minutes
  • Related substances: ≤1.5% total
  • Uniformity of dosage: USP compliance
  • Microbial limits: Pharmacopeial compliance
  • Batch-specific certification

Method of Analysis (MOA)

  • Validated HPLC methods
  • System suitability parameters
  • Specificity and selectivity
  • Linearity and range validation
  • Accuracy and precision data
  • LOD/LOQ determination

Batch Manufacturing Records (BMR)

  • Complete manufacturing formula
  • Raw material traceability
  • In-process control data
  • Equipment qualification status
  • Yield calculations
  • Deviation documentation

Validation Reports

  • Process validation (3 consecutive batches)
  • Cleaning validation (worst-case products)
  • Equipment qualification (IQ/OQ/PQ)
  • Analytical method validation
  • Stability indicating methods
  • Statistical analysis reports

OOS/OOT Management & Investigation

Comprehensive out-of-specification and out-of-trend investigation reports with corrective and preventive actions.

OOS Investigation Process

  • Immediate notification procedures
  • Phase I: Laboratory investigation
  • Phase II: Manufacturing investigation
  • Root cause analysis
  • Impact assessment
  • Batch disposition decisions

OOT Trend Analysis

  • Statistical trend monitoring
  • Control chart analysis
  • Early warning systems
  • CAPA implementation
  • Effectiveness verification
  • Continuous improvement

Quality Standards Compliance

Our quality documentation complies with international pharmacopeial standards and regulatory requirements.

Pharmacopeial Compliance

  • USP (United States Pharmacopeia)
  • EP (European Pharmacopeia)
  • BP (British Pharmacopeia)
  • IP (Indian Pharmacopeia)
  • WHO International Standards

ICH Guidelines

  • ICH Q7: GMP for APIs
  • ICH Q8: Pharmaceutical Development
  • ICH Q9: Quality Risk Management
  • ICH Q10: Pharmaceutical Quality System
  • ICH Q2: Analytical Validation

Regulatory Standards

  • WHO-GMP Guidelines
  • EU-GMP Annex 1
  • US FDA 21 CFR Part 211
  • PIC/S Guidelines
  • National Regulatory Requirements

Request Complete Quality Dossier Package

Get comprehensive quality documentation including COA, MOA, BMR, validation reports, and OOS/OOT management documentation.

📋 Request Quality Dossier 📚 All Regulatory Documents

For prescription and export purposes only. Use under medical supervision. Not intended for self-medication. Information for educational purposes. Export subject to local regulations.

© 2026 Fenbendazole Pharma. All Rights Reserved.
For prescription and export purposes only. Not intended for self-medication. Export subject to local regulations.